Nephrotoxicity from cancer immunotherapy

G. M. Dosik, J. U. Gutterman, E. M. Hersh, M. Akhtar, T. Sonoda, R. G. Horn

Research output: Contribution to journalArticlepeer-review

17 Scopus citations


Because systemic intravenous immunotherapy with Corynebacterium parvum is an effective immunopotentiating and immunotherapeutic agent in animals, clinical studies of this agent have been undertaken. Toxicities in man have been noted, but most are treated symptomatically. Three patients with metastatic melanoma developed oliguria, edema, diffuse bilateral pulmonary infiltrates, azotemia, hypoalbuminemia and hypocomplementemia, while receiving intravenous C. parvum therapy. All had renal biopsies that showed a proliferative glomerulonephritis with subendothelial basement membrane deposits. Immunofluorescence showed glomerular IgG, IgA, IgM, and the C3 component of complement. A fourth patient was found in retrospective chart review of 87 patients registered on two C. parvum-containing protocols. The frequency of the complication in this group was 3/87. Renal failure resolved in all four patients spontaneously after the cessation of C. parvum immunotherapy. Serial evaluation of renal function should be carried out in all patients on systemic adjuvant immunotherapy.

Original languageEnglish (US)
Pages (from-to)41-46
Number of pages6
JournalUnknown Journal
Issue number1
StatePublished - 1978
Externally publishedYes

ASJC Scopus subject areas

  • Internal Medicine


Dive into the research topics of 'Nephrotoxicity from cancer immunotherapy'. Together they form a unique fingerprint.

Cite this